发明名称 |
Water-soluble composition for sustained-release containing epo and hyaluronic acid |
摘要 |
(1) A composition which comprises erythropoietin and hyaluronic acid shows a sustained-release of the medicine in a living body, and (2) A water-soluble composition which comprises (a) a pharmacologically active polypeptide secreted by an animal body or its derivative or a chemically synthesized pharmacologically active substance, (b) a water-soluble species of hyaluronic acid or its nontoxic salt and (c) a water-soluble protein injectable into body fluids without showing any substantial pharmacological activity brings about a prolonged action in vivo of a pharmacologically active substance. In addition, the composition can be administered using a small-gauge needle and thereby contributes ot relieving pain in patients.
|
申请公布号 |
US5416071(A) |
申请公布日期 |
1995.05.16 |
申请号 |
US19920909160 |
申请日期 |
1992.07.06 |
申请人 |
TAKEDA CHEMICAL INDUSTRIES, LTD. |
发明人 |
IGARI, YASUTAKA;YAMADA, MINORU;OGAWA, YASUAKI |
分类号 |
A61K38/18;A61K47/36;A61K47/42;(IPC1-7):A61K38/14 |
主分类号 |
A61K38/18 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|